We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$13.7B
AUM Growth
+$1.01B
Cap. Flow
+$589M
Cap. Flow %
4.3%
Top 10 Hldgs %
11.63%
Holding
1,581
New
640
Increased
361
Reduced
263
Closed
311

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.4M
2
PFE icon
Pfizer
PFE
+$82.7M
3
MCD icon
McDonald's
MCD
+$65.4M
4
KDP icon
Keurig Dr Pepper
KDP
+$64.6M
5
ULTA icon
Ulta Beauty
ULTA
+$63.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.96%
2 Technology 16.17%
3 Consumer Discretionary 15.54%
4 Industrials 10.23%
5 Financials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVA icon
301
Innoviva
INVA
$1.53B
$10.7M 0.08%
822,356
+798,146
+3,297% +$10M
PGR icon
302
Progressive
PGR
$122B
$10.5M 0.08%
239,297
-163,203
-41% -$6.78M
MO icon
303
Altria Group
MO
$114B
$10.5M 0.08%
142,021
+25,085
+21% +$1.84M
MUSA icon
304
Murphy USA
MUSA
$10.9B
$10.5M 0.08%
+141,893
New +$9.93M
LSTR icon
305
Landstar System
LSTR
$6B
$10.4M 0.08%
121,471
+115,052
+1,792% +$9.75M
WMGI
306
DELISTED
Wright Medical Group Inc
WMGI
$10.4M 0.08%
+384,213
New +$10.9M
RVTY icon
307
Revvity
RVTY
$12.9B
$10.3M 0.08%
152,102
+36,916
+32% +$2.29M
DOV icon
308
Dover
DOV
$27.7B
$10.3M 0.08%
159,362
+58,584
+58% +$3.82M
ENOV icon
309
Enovis
ENOV
$1.81B
$10.3M 0.08%
153,378
+138,722
+947% +$9.46M
JBTM
310
JBT Marel
JBTM
$7.41B
$10.3M 0.07%
104,624
-11,249
-10% -$999K
FPRX
311
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$10.2M 0.07%
341,387
+56,058
+20% +$1.75M
LZB icon
312
La-Z-Boy
LZB
$1.64B
$10.2M 0.07%
310,138
+268,214
+640% +$7.53M
PPL
313
PPL Corp
PPL
$26.5B
$10.2M 0.07%
+261,811
New +$10.1M
VREX icon
314
Varex Imaging
VREX
$502M
$10.2M 0.07%
299,121
+208,044
+228% +$7.08M
TSRO
315
DELISTED
TESARO, Inc.
TSRO
$10.2M 0.07%
72,573
+33,316
+85% +$4.82M
GAP
316
The Gap Inc
GAP
$7.38B
$10.2M 0.07%
+461,696
New +$11M
MRO
317
DELISTED
Marathon Oil Corporation
MRO
$10.1M 0.07%
+841,280
New +$11.8M
LBTYK icon
318
Liberty Global Class C
LBTYK
$3.63B
$10.1M 0.07%
325,263
-378,876
-54% -$11.8M
FAST icon
319
Fastenal
FAST
$55.2B
$10.1M 0.07%
+916,156
New +$10.3M
WP
320
DELISTED
Worldpay, Inc.
WP
$10.1M 0.07%
159,637
+144,596
+961% +$9.08M
SIMO icon
321
Silicon Motion
SIMO
$8.53B
$10M 0.07%
208,508
+58,953
+39% +$2.92M
TSS
322
DELISTED
Total System Services, Inc.
TSS
$10M 0.07%
172,559
-139,307
-45% -$7.97M
SCG
323
DELISTED
Scana
SCG
$9.97M 0.07%
+148,835
New +$9.99M
PRGS icon
324
Progress Software
PRGS
$1.7B
$9.97M 0.07%
321,624
+205,366
+177% +$6.08M
FE icon
325
FirstEnergy
FE
$28B
$9.93M 0.07%
+342,442
New +$10.2M

Similar funds

Marshall Wace North America's Q2 2017 Portfolio in Review

As of Q2 2017, Marshall Wace North America held 1,581 positions worth $13.7B, up 8% from $12.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace North America deployed $589M of net new capital in Q2 2017, opening 640 new positions and adding to 361 existing holdings. Its largest new stake was Ulta Beauty: 218,927 shares worth $62.8M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was T-Mobile US, an estimated $225M trimmed.

  • Marshall Wace North America's largest Q2 2017 buy was Ulta Beauty: 218,927 shares worth $62.8M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q2 2017, an estimated $90.4M increase.
  • Marshall Wace North America's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $225M.
  • Marshall Wace North America fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 12% of its $13.7B portfolio in Q2 2017.
  • Marshall Wace North America opened 640 new positions and closed 311 in Q2 2017.
  • Marshall Wace North America's portfolio value rose 8% quarter-over-quarter to $13.7B.

Based on Marshall Wace North America's 13F filing for Q2 2017, filed 4 Aug 2017.